Organization
University of Pisa, Pisa, Italy
15 abstracts
Abstract
Phase II study in pediatric and AYA patients with non-metastatic high-grade extremity osteosarcoma with a risk-adapted strategy based on P-glycoprotein (ISG/OS-2): A correlative study on tumour immune microenvironment.Org: IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, IEO - Istituto Europeo di Oncologia IRCCS, Milan, Italy, Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, Istituto Ortopedico Gaetano Pini, Milan, Italy, University of Pisa, Pisa, Italy,
Abstract
Gut microbiome composition as predictor of the efficacy of adding atezolizumab to first-line FOLFOXIRI plus bevacizumab in metastatic colorectal cancer: A translational analysis of the AtezoTRIBE study.Org: University of Pisa, Pisa, Italy, Unit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana and Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy, Charité Universitätsmedizin Berlin, Berlin, Germany, Oncology Unit 1, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy, Department of Medical Oncology, University Campus Biomedico, Roma, Italy, Division of Clinical Pharmacology and Oncology, Department of Health Sciences, School of Psychology, University of Florence, Florence, Italy, University of Pisa, Pisa, Italy, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy and Oncology Unit 1 Veneto Institute of Oncology - IRCCS Padua, Padua, Italy, U.O.C. Oncologia Medica, Presidio Ospedaliero Livorno, Livorno, Italy, Hämatologisch Onkologische Praxis Eppendorf (HOPE) and Universitäres Cancer Center Hamburg, Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa, Italy, Department of Oncology, Istituto Scientifico San Raffaele IRCSS, Milan, Italy, CdC Poliambulanza, Brescia, Italy, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy and Oncology Unit 1 Veneto Institute of Oncology - IRCCS, Padua, Italy, IRCSS-CRO Aviano, Department of Clinical Oncology, Aviano, Italy, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, Martin Luther University, Halle, Germany, Azienda Ospedaliera Universitaria Pisana, Università degli Studi di Trento, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,
Abstract
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.Org: Sorbonne University and Saint-Antoine Hospital, Mayo Clinic, Monash University School of Public Health and Preventive Medicine, Cardiff University School of Medicine, University of Pisa, Pisa, Italy,
Abstract
Prognostic impact of depth of response (DpR) and early tumour shrinkage (ETS) in patients (pts) with BRAF V600E mutated (mut) metastatic colorectal cancer (mCRC) receiving targeted therapy (TT) as second-line treatment.Org: University of Pisa, Pisa, Italy, Azienda Ospedaliero-Universitaria Pisana, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Veneto Institute of Oncology IOV - IRCCS,
Abstract
Predictive impact of RNF43 mutation (mut) in pMMR/MSS BRAF V600E mutated metastatic colorectal cancer (mCRC) patients (pts) treated with target therapy (TT) or chemotherapy (CT).Org: University of Pisa, Pisa, Italy, Azienda Ospedaliero-Universitaria Pisana, Vall d’Hebron Institute of Oncology (VHIO), Veneto Institute of Oncology IOV–IRCCS, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,
Abstract
Exploring the prognostic and predictive impact of genomic loss of heterozygosity (LOH) in patients with metastatic colorectal cancer (mCRC).Org: Unit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana and Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy, Charité Universitätsmedizin Berlin, Berlin, Germany, Oncology Unit 1, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy, Department of Medical Oncology, University Campus Biomedico, Roma, Italy, Division of Clinical Pharmacology and Oncology, Department of Health Sciences, School of Psychology, University of Florence, Florence, Italy, University of Pisa, Pisa, Italy, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy and Oncology Unit 1 Veneto Institute of Oncology - IRCCS Padua, Padua, Italy, U.O.C. Oncologia Medica, Presidio Ospedaliero Livorno, Livorno, Italy, Hämatologisch Onkologische Praxis Eppendorf (HOPE) and Universitäres Cancer Center Hamburg, Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa, Italy, Department of Oncology, Istituto Scientifico San Raffaele IRCSS, Milan, Italy, CdC Poliambulanza, Brescia, Italy, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy and Oncology Unit 1 Veneto Institute of Oncology - IRCCS, Padua, Italy, IRCSS-CRO Aviano, Department of Clinical Oncology, Aviano, Italy, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, Martin Luther University, Halle, Germany, Azienda Ospedaliera Universitaria Pisana, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa & Unit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy, University of Pisa, Pisa, Italy, University Campus Biomedico,
Abstract
Profile of toxicities and quality of life in long-term survivors treated with immunotherapy: A prospective cross sectional trial.Org: University of Brescia, ASST Spedali Civili - Brescia, University Hospital of Parma, University of Pisa, Pisa, Italy, ATC Innovation Lab,
Abstract
2019 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF SYSTEMIC LUPUS ERYTHEMATOSUSOrg: University of Perugia, Perugia, Italy, University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany, Leiden University Medical Center, Leiden, Netherlands, University of Padova, Padova, Italy, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom,
Abstract
2019 UPDATE OF THE JOINT EUROPEAN LEAGUE AGAINST RHEUMATISM AND EUROPEAN RENAL ASSOCIATION–EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE MANAGEMENT OF LUPUS NEPHRITISOrg: University of Athens, Athens, Greece, G. Gennimatas General Hospital, Athens, Greece, University of Cambridge, Cambridge, Greece, University of Munich, Munich, Greece, University of Dresden, Dresden, Germany,
Abstract
ADULT ONSET STILL'S DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY OF 233 ITALIAN PATIENTS Org: Department of Medicine, University of Padova, Padova, La Sapienza University of Rome, Rome, University of Pavia, Pavia, Italy, University of Pisa, Pisa, Italy, University of Bari, Bari,
Abstract
ANTI-VCA AND EBNA1 ANTIBODIES ARE PRODUCED IN THE RHEUMATOID SYNOVIUM IN THE PRESENCE OF ECTOPIC LYMPHOID STRUCTURES AND CORRELATE WITH ACPA PRODUCTION Org: Queen Mary University of London, London, United Kingdom, Istituto Superiore di Sanita', Rome, University of Pisa, Pisa, Italy,
Abstract
Anti-neutrophil cytoplasmic antibodies positivity in interstitial lung disease patientsOrg: University of Pisa, Pisa, Italy, Medical Biotechnology, University of Siena, University and IRCCS Policlinico S. Matteo Foudation, Azienda Ospedaliera -Universitaria Integrata Trieste, Università degli Studi di Milano-Bicocca,
Abstract
BARICITINIB AND PULSE STEROIDS COMBINED TREATMENT IN SEVERE COVID-19 PNEUMONIA: PRELIMINARY DATA FROM A RHEUMATOLOGIC EXPERIENCE IN INTENSIVE CARE UNITOrg: Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa, Italy,
Abstract
BELIMUMAB REDUCES DISEASE FLARES VERSUS PLACEBO IN ADULTS WITH EARLY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A LARGE INTEGRATED ANALYSISOrg: GSK Research and Development Upper Providence, Collegeville, PA, Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology, Oklahoma City, United States of America, Brigham and Women’s Hospital, Hokkaido University Hospital Cancer Center, Amsterdam Rheumatology and Immunology Center | Reade, Amsterdam, Netherlands,
Abstract
A SYSTEMATIC LITERATURE REVIEW TO INFORM THE 2019 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUSOrg: University of Perugia, Perugia, Italy, University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany, Leiden University Medical Center, Leiden, Netherlands, Hospital Clinic, Barcelona, Spain, University of Padova, Padova, Italy,